Top Marijuana Shares from the NASDAQ

Top Marijuana Shares from the NASDAQ

Even though the almost all U.S.-based cannabis companies and many foreign American Depository Receipts (ADRs) trade throughout the countertop (OTC), a marijuana that is few are exchanged in the NASDAQ. Some investors choose shares which are noted on the NASDAQ with other exchanges because of their increased liquidity and tighter spreads set alongside the markets that are over-the-counter. As an example, due to the fact cannabis industry is continuing to grow in present months and years, uplisting from an OTC market to an established U.S. change is becoming an advertising achievement for most increasing cannabis organizations. (For associated reading, see “Understanding Medical Cannabis vs. Recreational Cannabis shares”)

An number that is increasing of organizations are now being noted on reputable U.S. exchanges instead of being traded regarding the OTC cbd oil for sale market showing the fast development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ ended up being the very first exchange that is electronic is certainly similar to technology and biotechnology. The cannabis businesses in the NASDAQ mirror this, while the greater part of them run within the area that is biotech of industry. Here you will find the marijuana that is NASDAQ-listed, in alphabetical purchase, at the time of October 26, 2019, with a failure of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is just a biotech business mixed up in production of medical cannabis drugs. Research and development around Arena’s APD371 may be the focus that is primary of company’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is a check this is certainly blank that is currently in a merger contract with Kalyx Development Inc. Kalyx is a respected owning a home rely upon the regulated cannabis industry in the usa.

Key Takeaways

  • The cannabis industry, specially the part of cannabis and biotech, is attracting investor attention that is substantial.
  • Cannabis will be utilized in brand brand new medications to treat discomfort and chronic that is many inflammatory, and fibrotic conditions.
  • Organizations may also be developing cannabinoid items for autism spectrum problems, schizophrenia, glioma, Tourette problem, epileptic disorders, Prader-Willi Syndrome (a hereditary condition), and amphetamine addiction.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is just a clinical-stage biotechnology business focused on developing and commercializing new chemical entities for the indications of discomfort and pruritus (itching). Although all of the firm’s clinical-stage services and products target opioid receptors, Cara is performing research that is preclinical cannabinoids for the treatment of neuropathic pain.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech business. The team’s research, development, and production are based around cannabis medications that look for to deal with chronic, inflammatory, fibrotic, along with other diseases.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is just A canadian cannabis company. The group has and seeks cannabis-related subsidiaries and licensed manufacturers. In December of 2018, Marlboro manufacturer Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to fund its continued expansion but additionally by having a well-established partner skilled into the advertising of consumer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is really a Boca Raton, Florida-based cannabis business. It distributes many different cannabis consumption add-ons and vaporization gear and services and products to customers that are retail the U.S. and Canada. Also, it operates websites that are e-commerce extra product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is having a profile of cannabinoid medications. These medications include Sativex to treat spasticity associated with sclerosis that is multiple cancer tumors discomfort and Epidiolex to treat childhood epilepsy. Sativex is commercialized much more compared to a dozen nations away from united states of america and contains received regulatory approval in some other nations. Epidiolex received Food And Drug Administration approval as a treatment for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very early beginning epilepsy without good existing treatment plans. Other indications show that GW Pharmaceuticals is developing cannabinoid services and products for autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is really a clinical-stage biopharmaceutical business that is developing drugs centered on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower back pain and fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based pest management and plant health services and products. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now appropriate to be used on cannabis plants within the Ca cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern age Beverages Corp. is a maker of beverages produced from yerba mate, green tea extract, kombucha, and similar products. In current months, New Age has expanded its beverage offerings to add CBD infusions aswell, bringing it to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted from the NASDAQ in May of 2019, which makes it perhaps one of the most present cannabis companies to list from the exchange that is popular. The business happens to be rapidly expanding its manufacturing capability and could have the ability to create up to 113,000 kilograms of item per year because of the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs into the enforcement sector. The business’s business operations support medication evaluating through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is yet another entry that is new the NASDAQ change. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) whenever it announced the production of a unique Palmetto make of leisure cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is a specialty clinical-stage company that is pharmaceutical regarding the growth of cannabinoid-based medications. Therapix’s present pipeline includes services and products targeted for the treatment of Tourette problem and mild impairment that is cognitive.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. had been initial marijuana-related business to have a preliminary public providing (IPO) in the us. The Nanaimo, Vancouver company that is island-based on medical cannabis services and products.

Village Farms Global (NASDAQ:VFF)

Village Farms Overseas is one of current cannabis stock to begin dealing on the NASDAQ. The business’s stocks became designed for trade on February 21, 2019. The business includes a history that is decades-long greenhouse produce manufacturing and contains only recently shifted a number of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted from the growth of synthetic treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline presently includes two medications being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.